Almasi Z, Rafiemanesh H, Salehiniya H. Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran. Asian Pac J Cancer Prev. 2015;16(7):2757–61.
Article
PubMed
Google Scholar
Ghoncheh M, Momenimovahed Z, Salehiniya H. Epidemiology, incidence and mortality of breast cancer in Asia. Asian Pac J Cancer Prev. 2016;17(S3):47–52.
Article
PubMed
Google Scholar
Mousavi SM, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13(4):383–91.
Article
PubMed
Google Scholar
Sharifian A, et al. Burden of Breast Cancer in Iranian Women is Increasing. Asian Pac J Cancer Prev. 2015;16(12):5049–52.
Article
PubMed
Google Scholar
Mahdavifar N, et al. Spatial analysis of breast cancer incidence in Iran. Asian Pac J Cancer Prev. 2016;17(S3):59–64.
Article
PubMed
Google Scholar
Afsharfard A, et al. Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev. 2013;14(11):6905–11.
Article
PubMed
Google Scholar
Abdulrahman GO, Rahman GA. Epidemiology of breast cancer in Europe and Africa. J Cancer Epidemiol. 2012;2012:915610.
Article
PubMed
Google Scholar
Leong SP, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34(10):2308–24.
Article
PubMed
PubMed Central
Google Scholar
Iqbal J, et al. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73.
Article
CAS
PubMed
Google Scholar
Welcsh PL, King MC. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet. 2001;10(7):705–13.
Article
CAS
PubMed
Google Scholar
Xu X, et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet. 1999;22(1):37–43.
Article
CAS
PubMed
Google Scholar
Sidransky D, et al. Inherited p53 gene mutations in breast cancer. Cancer Res. 1992;52(10):2984–6.
CAS
PubMed
Google Scholar
Tan MH, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012;18(2):400–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell. 2007;11(2):103–5.
Article
CAS
PubMed
Google Scholar
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.
Article
CAS
PubMed
Google Scholar
Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10(6):389–402.
Article
CAS
PubMed
PubMed Central
Google Scholar
Danesh H, et al. Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 polymorphisms and the risk of breast cancer in a sample of Iranian population. Gene. 2018;647:73–8.
Article
CAS
PubMed
Google Scholar
Zhang Y, et al. Estrogen receptor alpha signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem. 2012;287(49):41514–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heydari N, et al. Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer. Gene. 2018;655:25–9.
Article
CAS
PubMed
Google Scholar
Parchami Barjui S, et al. Study of correlation between genetic variants in three microRNA genes (hsa-miR-146a, hsa-miR-502 binding site, hsa-miR-27a) and breast cancer risk. Curr Res Transl Med. 2017;65(4):141–7.
Article
CAS
PubMed
Google Scholar
Omrani M, et al. Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med. 2014;8(2):259–67.
Article
CAS
PubMed
Google Scholar
Landi D, et al. A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. DNA Cell Biol. 2008;27(1):35–43.
Article
CAS
PubMed
Google Scholar
Hashemi M, et al. miR-608 rs4919510 C > G polymorphism decreased the risk of breast cancer in an Iranian subpopulation. Exp Oncol. 2016;38(1):57–9.
Article
CAS
PubMed
Google Scholar
Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008;68(19):8164–72.
Article
CAS
PubMed
Google Scholar
Qi L, et al. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer. 2009;9:163.
Article
PubMed
PubMed Central
CAS
Google Scholar
Savad S, et al. Expression analysis of MiR-21, MiR-205, and MiR-342 in breast cancer in Iran. Asian Pac J Cancer Prev. 2012;13(3):873–7.
Article
PubMed
Google Scholar
Zenz T, et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood. 2009;113(16):3801–8.
Article
CAS
PubMed
Google Scholar
Mansoori B, et al. Micro RNA 34a and Let-7a expression in human breast cancers is associated with apoptotic expression genes. Asian Pac J Cancer Prev. 2016;17(4):1887–90.
Article
PubMed
Google Scholar
Saberi A, et al. MiR-328 may be considered as an oncogene in human invasive breast carcinoma. Iran Red Crescent Med J. 2016;18(11):e42360.
PubMed
PubMed Central
Google Scholar
Damavandi Z, et al. Aberrant expression of breast development-related microRNAs, miR-22, miR-132, and miR-212, breast tumor tissues. J Breast Cancer. 2016;19(2):148–55.
Article
PubMed
PubMed Central
Google Scholar
Ma XP, et al. Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies. PLoS ONE. 2013;8(11):e79584.
Article
PubMed
PubMed Central
CAS
Google Scholar
Nejati-Azar A, Alivand MR. miRNA 196a2(rs11614913) & 146a(rs2910164) polymorphisms & breast cancer risk for women in an Iranian population. Per Med. 2018;15(4):279–89.
Article
CAS
PubMed
Google Scholar
Cai Y, He J, Zhang D. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. Onco Targets Ther. 2015;8:2657–64.
CAS
PubMed
PubMed Central
Google Scholar
Ling H, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23(9):1446–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sarrafzadeh S, et al. Expression study and clinical correlations of MYC and CCAT2 in breast cancer patients. Iran Biomed J. 2017;21(5):303–11.
Article
PubMed
PubMed Central
Google Scholar
Gupta RA, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hassanzarei S, et al. Genetic polymorphisms of HOTAIR gene are associated with the risk of breast cancer in a sample of southeast Iranian population. Tumour Biol. 2017;39(10):1010428317727539.
Article
PubMed
Google Scholar
Zhouravleva G, et al. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J. 1995;14(16):4065–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hoshino S, et al. Novel function of the eukaryotic polypeptide-chain releasing factor 3 (eRF3/GSPT) in the mRNA degradation pathway. Biochemistry (Mosc). 1999;64(12):1367–72.
CAS
Google Scholar
Hansen LL, Jakobsen CG, Justesen J. Assignment of the human peptide chain release factor 3 (GSPT2) to Xp11.23– > p11.21 and of the distal marker DXS1039 by radiation hybrid mapping. Cytogenet Cell Genet. 1999;86(3–4):250–1.
Article
CAS
PubMed
Google Scholar
Ozawa K, et al. Mapping of the human GSPT1 gene, a human homolog of the yeast GST1 gene, to chromosomal band 16p131. Somat Cell Mol Genet. 1992;18(2):189–94.
Article
CAS
PubMed
Google Scholar
Miri M, et al. GGCn polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility. Med Oncol. 2012;29(3):1581–5.
Article
CAS
PubMed
Google Scholar
Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004;22(22):4632–42.
Article
CAS
PubMed
Google Scholar
Ueland PM, et al. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci. 2001;22(4):195–201.
Article
CAS
PubMed
Google Scholar
Hosseini M, Houshmand M, Ebrahimi A. MTHFR polymorphisms and breast cancer risk. Arch Med Sci. 2011;7(1):134–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rezaei H, Rassi H, Mansur FN. Investigation of Methylenetetrahydrofolate reductase C677T polymorphism and human papilloma virus genotypes in Iranian breast cancer. Monoclon Antib Immunodiagn Immunother. 2017;36(3):124–8.
Article
CAS
PubMed
Google Scholar
Johansson HJ, et al. Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer. Nat Commun. 2013;4:2175.
Article
PubMed
CAS
Google Scholar
Jahangiri R, et al. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients. Gene. 2018;685:24–31.
Article
PubMed
CAS
Google Scholar
Eftekhar E, et al. The study of DNA methyltransferase-3B promoter variant genotype among iranian sporadic breast cancer patients. Iran J Med Sci. 2014;39(3):268–74.
PubMed
PubMed Central
Google Scholar
Ghavami S, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet. 2009;46(8):497–510.
Article
CAS
PubMed
Google Scholar
Hashemi M, et al. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6 N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene. 2012;505(1):176–9.
Article
CAS
PubMed
Google Scholar
Aghababazadeh M, et al. Downregulation of Caspase 8 in a group of Iranian breast cancer patients—a pilot study. J Egypt Natl Canc Inst. 2017;29(4):191–5.
Article
PubMed
Google Scholar
Parant JM, Lozano G. Disrupting TP53 in mouse models of human cancers. Hum Mutat. 2003;21(3):321–6.
Article
CAS
PubMed
Google Scholar
Eskandari-Nasab E, et al. Effect of TP53 16-bp and beta-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer. Gene. 2015;568(2):181–5.
Article
CAS
PubMed
Google Scholar
Payandeh M, et al. Expression of p53 breast cancer in kurdish women in the West of Iran: a reverse correlation with lymph node metastasis. Asian Pac J Cancer Prev. 2016;17(3):1261–4.
Article
PubMed
Google Scholar
Chipuk JE, et al. The BCL-2 family reunion. Mol Cell. 2010;37(3):299–310.
Article
CAS
PubMed
PubMed Central
Google Scholar
Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 2011;21(1):92–101.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rostamizadeh L, et al. Bcl-2 gene expression in human breast cancers in iran. Asian Pac J Cancer Prev. 2013;14(7):4209–14.
Article
PubMed
Google Scholar
Freeman DJ, et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell. 2003;3(2):117–30.
Article
CAS
PubMed
Google Scholar
Li AG, et al. Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell. 2006;23(4):575–87.
Article
PubMed
CAS
Google Scholar
Golmohammadi R, et al. Prognostic role of PTEN gene expression in breast cancer patients from north-east Iran. Asian Pac J Cancer Prev. 2016;17(9):4527–31.
PubMed
Google Scholar
Sadeq V, Isar N, Manoochehr T. Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation. Med Oncol. 2011;28(2):420–3.
Article
CAS
PubMed
Google Scholar
Yari K, Payandeh M, Rahimi Z. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran. Tumour Biol. 2016;37(6):8145–52.
Article
CAS
PubMed
Google Scholar
Ghaffari K, et al. BIRC5 genomic copy number variation in early-onset breast cancer. Iran Biomed J. 2016;20(4):241–5.
PubMed
PubMed Central
Google Scholar
Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res. 2001;264(1):42–55.
Article
CAS
PubMed
Google Scholar
Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366(6456):704–7.
Article
CAS
PubMed
Google Scholar
Nielsen NH, et al. Methylation of the p16(Ink4a) tumor suppressor gene 5′-CpG island in breast cancer. Cancer Lett. 2001;163(1):59–69.
Article
CAS
PubMed
Google Scholar
Kannan K, et al. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc Natl Acad Sci USA. 2003;100(3):1221–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Malumbres M, et al. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Mol Cell Biol. 2000;20(8):2915–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vallian S, et al. Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer. J Cancer Res Clin Oncol. 2009;135(8):991–6.
Article
CAS
PubMed
Google Scholar
Khanna KK. Cancer risk and the ATM gene: a continuing debate. J Natl Cancer Inst. 2000;92(10):795–802.
Article
CAS
PubMed
Google Scholar
Salimi M, Mozdarani H, Majidzadeh K. Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients. Med Oncol. 2012;29(3):1502–9.
Article
CAS
PubMed
Google Scholar
Mehdipour P, et al. Importance of ATM gene as a susceptible trait: predisposition role of D1853 N polymorphism in breast cancer. Med Oncol. 2011;28(3):733–7.
Article
CAS
PubMed
Google Scholar
Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature. 1999;401(6750):297–300.
Article
CAS
PubMed
Google Scholar
Amininia S, et al. Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population. Med Oncol. 2014;31(10):189.
Article
PubMed
CAS
Google Scholar
Yoshihara T, Collado D, Hamaguchi M. Cyclin D1 down-regulation is essential for DBC2′s tumor suppressor function. Biochem Biophys Res Commun. 2007;358(4):1076–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Siripurapu V, et al. DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways. J Mol Biol. 2005;346(1):83–9.
Article
CAS
PubMed
Google Scholar
Hajikhan Mirzaei M, et al. Evaluation of Methylation Status in the 5′UTR Promoter Region of the DBC2 Gene as a Biomarker in Sporadic Breast Cancer. Cell J. 2012;14(1):19–24.
PubMed
PubMed Central
Google Scholar
Golmohammadi R, et al. A single nucleotide polymorphism in codon F31I and V57I of the AURKA gene in invasive ductal breast carcinoma in Middle East. Medicine (Baltimore). 2017;96(37):e7933.
Article
CAS
Google Scholar
Mojgan H, Massoud H, Ahmad E. ERCC1 intron 1 was associated with breast cancer risk. Arch Med Sci. 2012;8(4):655–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dai L, et al. XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: a meta-analysis of case–control studies. Int J Cancer. 2009;125(5):1102–9.
Article
CAS
PubMed
Google Scholar
Yu H, et al. Interaction between XRCC1 polymorphisms and intake of long-term stored rice in the risk of esophageal squamous cell carcinoma: a case-control study. Biomed Environ Sci. 2011;24(3):268–74.
PubMed
Google Scholar
Jalali C, et al. Association of XRCC1 Trp194 allele with risk of breast cancer, and Ki67 protein status in breast tumor tissues. Saudi Med J. 2016;37(6):624–30.
Article
PubMed
PubMed Central
Google Scholar
Liu L, et al. Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer. Carcinogenesis. 2012;33(1):119–23.
Article
PubMed
CAS
Google Scholar
Shen B, et al. Multiple but dissectible functions of FEN-1 nucleases in nucleic acid processing, genome stability and diseases. BioEssays. 2005;27(7):717–29.
Article
CAS
PubMed
Google Scholar
Rezaei M, et al. FEN1 -69G > A and +4150G > T polymorphisms and breast cancer risk. Biomed Rep. 2016;5(4):455–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002;108(2):171–82.
Article
CAS
PubMed
Google Scholar
Madjd Z, et al. Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomas. Asian Pac J Cancer Prev. 2014;15(4):1783–9.
Article
PubMed
Google Scholar
Gatei M, et al. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 2000;60(12):3299–304.
CAS
PubMed
Google Scholar
Moynahan ME, et al. Brca1 controls homology-directed DNA repair. Mol Cell. 1999;4(4):511–8.
Article
CAS
PubMed
Google Scholar
Hallajian Z, Mahjoubi F, Nafissi N. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients. Breast Cancer. 2017;24(4):624–34.
Article
PubMed
Google Scholar
Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 2006;34(5):1416–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Paterson JW. BRCA1: a review of structure and putative functions. Dis Markers. 1998;13(4):261–74.
Article
CAS
PubMed
Google Scholar
Darbeheshti F, et al. Comparison of BRCA1 expression between triple-negative and luminal breast tumors. Iran Biomed J. 2018;22(3):210–4.
PubMed
PubMed Central
Google Scholar
Madjd Z, et al. BRCA1 protein expression level and CD44(+)phenotype in breast cancer patients. Cell J. 2011;13(3):155–62.
PubMed
PubMed Central
Google Scholar
Rezaei M, et al. APOBEC3 deletion is associated with breast cancer risk in a sample of southeast Iranian population. Int J Mol Cell Med. 2015;4(2):103–8.
CAS
PubMed
PubMed Central
Google Scholar
Hussain S, et al. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet. 2003;12(19):2503–10.
Article
CAS
PubMed
Google Scholar
Abbasi S, Rasouli M. A rare FANCA gene variation as a breast cancer susceptibility allele in an Iranian population. Mol Med Rep. 2017;15(6):3983–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Basu N, et al. Telomeres and telomere dynamics: relevance to cancers of the GI tract. Expert Rev Gastroenterol Hepatol. 2013;7(8):733–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vodenicharov MD, Wellinger RJ. The cell division cycle puts up with unprotected telomeres: cell cycle regulated telomere uncapping as a means to achieve telomere homeostasis. Cell Cycle. 2007;6(10):1161–7.
Article
CAS
PubMed
Google Scholar
Gomez DE, et al. Telomere structure and telomerase in health and disease (review). Int J Oncol. 2012;41(5):1561–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hashemi M, et al. Association between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population. BMC Res Notes. 2014;7:895.
Article
PubMed
PubMed Central
CAS
Google Scholar
Burnet M. Cancer; a biological approach. I. The processes of control. Br Med J. 1957;1(5022):779–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Elliott RL, et al. Human leukocyte antigen G expression in breast cancer: role in immunosuppression. Cancer Biother Radiopharm. 2011;26(2):153–7.
Article
CAS
PubMed
Google Scholar
Pistillo MP, et al. Biochemical analysis of HLA class I subunits expression in breast cancer tissues. Hum Immunol. 2000;61(4):397–407.
Article
CAS
PubMed
Google Scholar
Salih HR, Nussler V. Commentary: immune escape versus tumor tolerance: how do tumors evade immune surveillance? Eur J Med Res. 2001;6(8):323–32.
CAS
PubMed
Google Scholar
Tripathi P, Agrawal S. Non-classical HLA-G antigen and its role in the cancer progression. Cancer Invest. 2006;24(2):178–86.
Article
CAS
PubMed
Google Scholar
Haghi M, et al. 14-bp insertion/deletion polymorphism of the HLA-G gene in breast cancer among women from north western Iran. Asian Pac J Cancer Prev. 2015;16(14):6155–8.
Article
PubMed
Google Scholar
Mahmoodi M, et al. HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer. Pathol Oncol Res. 2012;18(1):49–55.
Article
CAS
PubMed
Google Scholar
Ghaderi A, et al. HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer. Pathol Oncol Res. 2001;7(1):39–41.
Article
CAS
PubMed
Google Scholar
Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol. 2003;111(4):677–90 (quiz 691).
Article
CAS
PubMed
Google Scholar
Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425–56.
Article
CAS
PubMed
Google Scholar
Faghih Z, et al. Interleukin13 haplotypes and susceptibility of Iranian women to breast cancer. Mol Biol Rep. 2009;36(7):1923–8.
Article
CAS
PubMed
Google Scholar
Owaki T, et al. A role for IL-27 in early regulation of Th1 differentiation. J Immunol. 2005;175(4):2191–200.
Article
CAS
PubMed
Google Scholar
Pflanz S, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 + T cells. Immunity. 2002;16(6):779–90.
Article
CAS
PubMed
Google Scholar
Oppmann B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13(5):715–25.
Article
CAS
PubMed
Google Scholar
Aggarwal S, et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278(3):1910–4.
Article
CAS
PubMed
Google Scholar
Zheng Y, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445(7128):648–51.
Article
CAS
PubMed
Google Scholar
Khodadadi A, et al. IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer. Iran J Med Sci. 2014;39(4):350–6.
PubMed
PubMed Central
Google Scholar
Vahedi L, et al. Investigation of CCR120 marker expression using immunohistochemical method and its association with clinicopathologic properties in patients with breast cancer. Int J Hematol Oncol Stem Cell Res. 2018;12(2):103–10.
PubMed
PubMed Central
Google Scholar
Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol. 2002;22(2):105–14.
Article
CAS
PubMed
Google Scholar
Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer. 2010;127(4):759–67.
CAS
PubMed
Google Scholar
Jafarzadeh A, et al. Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism. Tumour Biol. 2015;36(2):1163–71.
Article
CAS
PubMed
Google Scholar
Dayer R, et al. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: a potent biomarker predicting lymph node metastasis. J Cancer Res Ther. 2018;14(2):345–50.
PubMed
Google Scholar
Fontenot JD, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22(3):329–41.
Article
CAS
PubMed
Google Scholar
Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057–61.
Article
CAS
PubMed
Google Scholar
Jaberipour M, et al. Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer. Pathol Oncol Res. 2010;16(4):547–51.
Article
CAS
PubMed
Google Scholar
Hamidinia M, et al. Concomitant Increase of OX40 and FOXP3 transcripts in peripheral blood of patients with breast cancer. Iran J Immunol. 2013;10(1):22–30.
CAS
PubMed
Google Scholar
Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123(3):627–35.
Article
PubMed
Google Scholar
Iyengar NM, Hudis CA, Dannenberg AJ. Obesity and inflammation: new insights into breast cancer development and progression. Am Soc Clin Oncol Educ Book. 2013;1:46–51.
Article
Google Scholar
Pierce BL, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol. 2009;27(21):3437–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer. 2007;14(2):189–206.
Article
CAS
PubMed
Google Scholar
Guo S, et al. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2012;1825(2):207–22.
CAS
PubMed
PubMed Central
Google Scholar
Rostami S, Kohan L, Mohammadianpanah M. The LEP G-2548A gene polymorphism is associated with age at menarche and breast cancer susceptibility. Gene. 2015;557(2):154–7.
Article
CAS
PubMed
Google Scholar
Babaei Z, et al. Relationship of obesity with serum concentrations of leptin, CRP and IL-6 in breast cancer survivors. J Egypt Natl Canc Inst. 2015;27(4):223–9.
Article
PubMed
Google Scholar
Mohammadzadeh G, et al. The relationship between -2548 G/A Leptin gene polymorphism and risk of breast cancer and serum leptin levels in Ahvazian women. Iran J Cancer Prev. 2015;8(2):100–8.
PubMed
PubMed Central
Google Scholar
Basu B, et al. D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells. J Biol Chem. 2010;285(35):27026–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63(1):182–217.
Article
CAS
PubMed
Google Scholar
Kirillova GP, et al. Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays. J Neurosci Methods. 2008;174(2):272–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pornour M, et al. Dopamine receptor gene (DRD1-DRD5) expression changes as stress factors associated with breast cancer. Asian Pac J Cancer Prev. 2014;15(23):10339–43.
Article
PubMed
Google Scholar
Amani D, et al. Transforming growth factor beta1 (TGFbeta1) polymorphisms and breast cancer risk. Tumour Biol. 2014;35(5):4757–64.
Article
CAS
PubMed
Google Scholar
Parvizi S, et al. Effects of two common promoter polymorphisms of transforming growth factor-beta1 on breast cancer risks in Ahvaz, west south of Iran. Iran J Cancer Prev. 2016;9(1):e5266.
PubMed
PubMed Central
Google Scholar
Tabatabaeian H, Hojati Z. Assessment of HER-2 gene overexpression in Isfahan province breast cancer patients using Real Time RT-PCR and immunohistochemistry. Gene. 2013;531(1):39–43.
Article
CAS
PubMed
Google Scholar
Panahi M, et al. Expressional correlation of human epidermal growth factor receptor 2, estrogen/progesterone receptor and protein 53 in breast cancer. Asian Pac J Cancer Prev. 2013;14(6):3699–703.
Article
PubMed
Google Scholar
Amirifard N, et al. Relationship between HER2 proto-oncogene status and prognostic factors of breast cancer in the west of Iran. Asian Pac J Cancer Prev. 2016;17(1):295–8.
Article
PubMed
Google Scholar
Salimi Z, et al. rs11895168 C allele and the increased risk of breast cancer in Isfahan population. Breast. 2016;28:89–94.
Article
PubMed
Google Scholar
Mansouri Bidkani M, et al. ErbB4 receptor polymorphism 2368A > C and risk of breast cancer. Breast. 2018;42:157–63.
Article
PubMed
Google Scholar
Bagheri F, et al. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3′-untranslated region of ErbB4 in breast cancer. Mol Med Rep. 2016;13(5):4494–8.
Article
CAS
PubMed
Google Scholar
Normanno N, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366(1):2–16.
Article
CAS
PubMed
Google Scholar
Zhang XM, et al. Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. World J Gastroenterol. 2003;9(8):1729–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang L, et al. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem. 2005;95(1):64–73.
Article
CAS
PubMed
Google Scholar
Eskandari-Nasab E, et al. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Mol Biol Rep. 2012;39(12):10531–9.
Article
CAS
PubMed
Google Scholar
Naik A, et al. Neuropilin-1 associated molecules in the blood distinguish poor prognosis breast cancer: a cross-sectional study. Sci Rep. 2017;7(1):3301.
Article
PubMed
PubMed Central
CAS
Google Scholar
Seifi-Alan M, et al. Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues. Cancer Manag Res. 2018;10:1969–74.
Article
PubMed
PubMed Central
Google Scholar
Cleveland RJ, et al. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis. 2006;27(4):758–65.
Article
CAS
PubMed
Google Scholar
Javadi M, Hematti S, Tavassoli M. Polymorphic CA repeat length in insulin-like growth factor 1 and risk of breast cancer in Iranian women. Med Oncol. 2012;29(2):516–20.
Article
CAS
PubMed
Google Scholar
Vanhaesebroeck B, Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res. 1999;253(1):239–54.
Article
CAS
PubMed
Google Scholar
Azizi Tabesh G, et al. The high frequency of PIK3CA mutations in iranian breast cancer patients. Cancer Invest. 2017;35(1):36–42.
Article
CAS
PubMed
Google Scholar
Sanaei S, et al. KRAS gene polymorphisms and their impact on breast cancer risk in an Iranian population. Asian Pac J Cancer Prev. 2017;18(5):1301–5.
PubMed
PubMed Central
Google Scholar
Nazouri AS, et al. High expression of sphingosine kinase 1 in estrogen and progesterone receptors-negative breast cancer. Iran J Pathol. 2017;12(3):218–24.
PubMed
PubMed Central
Google Scholar
Bunney TD, Katan M. Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer. 2010;10(5):342–52.
Article
CAS
PubMed
Google Scholar
Zhao L, Vogt PK. Class I PI3K in oncogenic cellular transformation. Oncogene. 2008;27(41):5486–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 2008;27(41):5497–510.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heshmatpour N, et al. Association between the lengths of GT dinucleotide repeat in the PIK3CA gene with breast cancer risk. Med Oncol. 2014;31(7):29.
Article
PubMed
CAS
Google Scholar
Ghalaei A, et al. Overexpressed in colorectal carcinoma gene (OCC-1) upregulation and APPL2 gene downregulation in breast cancer specimens. Mol Biol Rep. 2018;45(6):1889–95.
Article
CAS
PubMed
Google Scholar
Karami-Tehrani F, et al. Evaluation of RIP1K and RIP3K expressions in the malignant and benign breast tumors. Tumour Biol. 2016;37(7):8849–56.
Article
CAS
PubMed
Google Scholar
Lipkowitz S. The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer. Breast Cancer Res. 2003;5(1):8–15.
Article
CAS
PubMed
Google Scholar
Nikseresht M, et al. Overexpression of the novel human gene, UBE2Q2, in breast cancer. Cancer Genet Cytogenet. 2010;197(2):101–6.
Article
CAS
PubMed
Google Scholar
Vogl FD, et al. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev. 2004;13(9):1473–9.
CAS
PubMed
Google Scholar
Hashemi M, et al. Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population. Biomark Med. 2012;6(6):797–803.
Article
CAS
PubMed
Google Scholar
Sharif MR, et al. Association of GSTO1 A140D and GSTO2 N142D gene variations with breast cancer risk. Asian Pac J Cancer Prev. 2017;18(6):1723–7.
PubMed
PubMed Central
Google Scholar
Petersen DD, et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet. 1991;48(4):720–5.
CAS
PubMed
PubMed Central
Google Scholar
Saadatian H, et al. Polymorphism of the cytochrome P-450 1A1 (A2455G) in women with breast cancer in Eastern Azerbaijan, Iran. Iran J Basic Med Sci. 2014;17(3):227–30.
PubMed
PubMed Central
Google Scholar
Saghafi F, et al. CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen. Biomed Rep. 2018;9(5):446–52.
PubMed
PubMed Central
Google Scholar
Darakhshan S, et al. Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 regulation in cultured human breast cancer cells. Asian Pac J Cancer Prev. 2013;14(11):6869–74.
Article
PubMed
Google Scholar
Motamedi S, et al. Tamoxifen resistance and CYP2D6 copy numbers in breast cancer patients. Asian Pac J Cancer Prev. 2012;13(12):6101–4.
Article
PubMed
Google Scholar
Meiyanto E, Hermawan A, Anindyajati A. Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac J Cancer Prev. 2012;13(2):427–36.
Article
PubMed
Google Scholar
Lash TL, et al. CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark. J Natl Cancer Inst. 2011;103(6):489–500.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yazdi MF, et al. CYP2D6 genotype and risk of recurrence in tamoxifen treated breast cancer patients. Asian Pac J Cancer Prev. 2015;16(15):6783–7.
Article
PubMed
Google Scholar
Ciocca DR, et al. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst. 1993;85(19):1558–70.
Article
CAS
PubMed
Google Scholar
Mehlen P, et al. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J Immunol. 1995;154(1):363–74.
CAS
PubMed
Google Scholar
Calderwood SK, et al. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 2006;31(3):164–72.
Article
CAS
PubMed
Google Scholar
Vidyasagar A, Wilson NA, Djamali A. Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target. Fibrogenesis Tissue Repair. 2012;5(1):7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Homaei-Shandiz F, et al. Anti-heat shock protein-27 antibody levels in women with breast cancer: association with disease complications and two-year disease-free survival. Asian Pac J Cancer Prev. 2016;17(10):4655–9.
PubMed
PubMed Central
Google Scholar
Bruhn O, Cascorbi I. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance. Expert Opin Drug Metab Toxicol. 2014;10(10):1337–54.
Article
CAS
PubMed
Google Scholar
Durmus S, Hendrikx JJ, Schinkel AH. Apical ABC transporters and cancer chemotherapeutic drug disposition. Adv Cancer Res. 2015;125:1–41.
Article
CAS
PubMed
Google Scholar
Ghafouri H, et al. Association of ABCB1 and ABCG2 single nucleotide polymorphisms with clinical findings and response to chemotherapy treatments in Kurdish patients with breast cancer. Tumour Biol. 2016;37(6):7901–6.
Article
CAS
PubMed
Google Scholar
Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev. 2013;32(3–4):643–71.
Article
CAS
PubMed
Google Scholar
Estiar MA, et al. High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer. Clin Exp Med. 2017;17(4):547–53.
Article
CAS
PubMed
Google Scholar
Thriveni K, Krishnamoorthy L, Ramaswamy G. Correlation study of Carcino Embryonic Antigen & Cancer Antigen 15.3 in pretreated female breast cancer patients. Indian J Clin Biochem. 2007;22(1):57–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Duffy MJ. CA 15-3 and related mucins as circulating markers in breast cancer. Ann Clin Biochem. 1999;36(Pt 5):579–86.
Article
CAS
PubMed
Google Scholar
Moazzezy N, et al. Relationship between preoperative serum CA 15-3 and CEA levels and clinicopathological parameters in breast cancer. Asian Pac J Cancer Prev. 2014;15(4):1685–8.
Article
PubMed
Google Scholar
Mansouri N, et al. Overexpression of the MUC1 gene in Iranian women with breast cancer micrometastasis. Asian Pac J Cancer Prev. 2016;17(S3):275–8.
Article
PubMed
Google Scholar
Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005;6(8):622–34.
Article
CAS
PubMed
Google Scholar
Tepass U, et al. Cadherins in embryonic and neural morphogenesis. Nat Rev Mol Cell Biol. 2000;1(2):91–100.
Article
CAS
PubMed
Google Scholar
Zarei F, et al. Higher risk of progressing breast cancer in Kurdish population associated to CDH1 -160 C/A polymorphism. EXCLI J. 2017;16:1198–205.
PubMed
PubMed Central
Google Scholar
Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997;71:241–319.
Article
CAS
PubMed
Google Scholar
Esmaeili R, et al. Unique CD44 intronic SNP is associated with tumor grade in breast cancer: a case control study and in silico analysis. Cancer Cell Int. 2018;18:28.
Article
PubMed
PubMed Central
CAS
Google Scholar
Maetzel D, et al. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol. 2009;11(2):162–71.
Article
CAS
PubMed
Google Scholar
Gottlinger HG, et al. The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int J Cancer. 1986;38(1):47–53.
Article
CAS
PubMed
Google Scholar
Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008;8(12):976–90.
Article
CAS
PubMed
Google Scholar
Sadeghi S, Hojati Z, Tabatabaeian H. Cooverexpression of EpCAM and c-myc genes in malignant breast tumours. J Genet. 2017;96(1):109–18.
Article
CAS
PubMed
Google Scholar
Maguer-Satta V, Besancon R, Bachelard-Cascales E. Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells. 2011;29(3):389–96.
Article
CAS
PubMed
Google Scholar
Taghizadeh-Kermani A, et al. The stromal overexpression of CD10 in invasive breast cancer and its association with clincophathologic factors. Iran J Cancer Prev. 2014;7(1):17–21.
PubMed
PubMed Central
Google Scholar
Fridolfsson HN, et al. Regulation of intracellular signaling and function by caveolin. FASEB J. 2014;28(9):3823–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Williams TM, et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem. 2004;279(49):51630–46.
Article
CAS
PubMed
Google Scholar
Fard ZT, Nafisi N. The relationship between 6 polymorphisms of Caveolin-1 gene and the risk of breast cancer. Clin Breast Cancer. 2018;18(5):e893–8.
Article
CAS
PubMed
Google Scholar
Mobasheri MB, Shirkoohi R, Modarressi MH. Synaptonemal complex protein 3 transcript analysis in breast cancer. Iran J Public Health. 2016;45(12):1618–24.
PubMed
PubMed Central
Google Scholar
Malek-Hosseini Z, et al. Elevated Syndecan-1 levels in the sera of patients with breast cancer correlate with tumor size. Breast Cancer. 2017;24(6):742–7.
Article
PubMed
Google Scholar
Rehman G, et al. Role of AMP-activated protein kinase in cancer therapy. Arch Pharm (Weinheim). 2014;347(7):457–68.
Article
CAS
Google Scholar
Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev. 1995;75(4):725–48.
Article
CAS
PubMed
Google Scholar
Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J. 1993;7(2):328–38.
Article
CAS
PubMed
Google Scholar
Karami-Tehrani F, et al. Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors. Arch Med Res. 2012;43(6):470–5.
Article
CAS
PubMed
Google Scholar
Fiscus RR, Murad F. cGMP-dependent protein kinase activation in intact tissues. Methods Enzymol. 1988;159:150–9.
Article
CAS
PubMed
Google Scholar
Karami-Tehrani F, Fallahian F, Atri M. Expression of cGMP-dependent protein kinase, PKGIalpha, PKGIbeta, and PKGII in malignant and benign breast tumors. Tumour Biol. 2012;33(6):1927–32.
Article
CAS
PubMed
Google Scholar
Moghbeli M, et al. Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma. J Cell Commun Signal. 2016;10(2):129–35.
Article
PubMed
PubMed Central
Google Scholar
Moghbeli M, et al. Role of Msi1 and MAML1 in regulation of notch signaling pathway in patients with esophageal squamous cell carcinoma. J Gastrointest Cancer. 2015;46(4):365–9.
Article
CAS
PubMed
Google Scholar
Paryan M, et al. Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma. 3 Biotech. 2016;6(1):58.
Article
PubMed
PubMed Central
Google Scholar
Moghbeli M, et al. Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion. J Cell Commun Signal. 2016;10(1):49–53.
Article
PubMed
Google Scholar
Taghavi A, et al. Gene expression profiling of the 8q22-24 position in human breast cancer: TSPYL5, MTDH, ATAD2 and CCNE2 genes are implicated in oncogenesis, while WISP1 and EXT1 genes may predict a risk of metastasis. Oncol Lett. 2016;12(5):3845–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moghbeli M, et al. Cancer stem cell detection and isolation. Med Oncol. 2014;31(9):69.
Article
PubMed
CAS
Google Scholar
Balicki D. Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1. Cell Stem Cell. 2007;1(5):485–7.
Article
CAS
PubMed
Google Scholar
Ginestier C, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Madjd Z, et al. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas. Asian Pac J Cancer Prev. 2012;13(6):2973–8.
Article
PubMed
Google Scholar
Mandlekar S, Kong AN. Mechanisms of tamoxifen-induced apoptosis. Apoptosis. 2001;6(6):469–77.
Article
CAS
PubMed
Google Scholar
Yu FL, Bender W. A proposed mechanism of tamoxifen in breast cancer prevention. Cancer Detect Prev. 2002;26(5):370–5.
Article
CAS
PubMed
Google Scholar
Musgrove EA, Sutherland RL. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer. 2009;9(9):631–43.
Article
CAS
PubMed
Google Scholar
Eccles MR, et al. PAX genes in development and disease: the role of PAX2 in urogenital tract development. Int J Dev Biol. 2002;46(4):535–44.
CAS
PubMed
Google Scholar
Jahangiri R, et al. PAX2 expression is correlated with better survival in tamoxifen-treated breast carcinoma patients. Tissue Cell. 2018;52:135–42.
Article
CAS
PubMed
Google Scholar
Vervoorts J, Luscher-Firzlaff J, Luscher B. The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem. 2006;281(46):34725–9.
Article
CAS
PubMed
Google Scholar
Qu X, et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem. 2002;229(1–2):35–44.
Article
CAS
PubMed
Google Scholar
Zhao W, et al. Cloning and expression pattern of the human NDRG3 gene. Biochim Biophys Acta. 2001;1519(1–2):134–8.
Article
CAS
PubMed
Google Scholar
Estiar MA, et al. Clinical significance of NDRG3 in patients with breast cancer. Future Oncol. 2017;13(11):961–9.
Article
CAS
PubMed
Google Scholar
Hosseini A, et al. Estrogen receptor alpha gene expression in breast cancer tissues from the Iranian population–a pilot study. Asian Pac J Cancer Prev. 2014;15(20):8789–91.
Article
PubMed
Google Scholar
Abbasi S, et al. Association of estrogen receptor-alpha A908G (K303R) mutation with breast cancer risk. Int J Clin Exp Med. 2013;6(1):39–49.
CAS
PubMed
Google Scholar
Farzaneh F, et al. Analysis of CYP17, CYP19 and CYP1A1 Gene polymorphisms in Iranian women with breast cancer. Asian Pac J Cancer Prev. 2016;17(S3):23–6.
Article
PubMed
Google Scholar
Duncan LJ, Coldham NG, Reed MJ. The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells. J Steroid Biochem Mol Biol. 1994;49(1):63–8.
Article
CAS
PubMed
Google Scholar
Newman SP, et al. Regulation of steroid sulphatase expression and activity in breast cancer. J Steroid Biochem Mol Biol. 2000;75(4–5):259–64.
Article
CAS
PubMed
Google Scholar
Danforth DN, Sgagias MK. Tumour necrosis factor-alpha modulates oestradiol responsiveness of MCF-7 breast cancer cells in vitro. J Endocrinol. 1993;138(3):517–28.
Article
CAS
PubMed
Google Scholar
Roodi N, et al. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst. 1995;87(6):446–51.
Article
CAS
PubMed
Google Scholar
Kamali-Sarvestani E, et al. Association of TNF-alpha and TNF-beta gene polymorphism with steroid receptor expression in breast cancer patients. Pathol Oncol Res. 2005;11(2):99–102.
Article
CAS
PubMed
Google Scholar
Di C, et al. Basophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammation. J Biol Chem. 2015;290(20):12523–36.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee J, et al. Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses. Immunology. 2008;125(2):229–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ohshima Y, et al. Expression and function of OX40 ligand on human dendritic cells. J Immunol. 1997;159(8):3838–48.
CAS
PubMed
Google Scholar
Vakil R, Mashayekhi F. OX40L gene polymorphism and breast cancer in Iranian population. Exp Oncol. 2018;40(2):132–5.
Article
Google Scholar
Crew KD. Vitamin d: are we ready to supplement for breast cancer prevention and treatment? ISRN Oncol. 2013;2013:483687.
PubMed
PubMed Central
Google Scholar
Jurutka PW, et al. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord. 2001;2(2):203–16.
Article
CAS
PubMed
Google Scholar
Thorne J, Campbell MJ. The vitamin D receptor in cancer. Proc Nutr Soc. 2008;67(2):115–27.
Article
CAS
PubMed
Google Scholar
Barsony J, Prufer K. Vitamin D receptor and retinoid X receptor interactions in motion. Vitam Horm. 2002;65:345–76.
Article
CAS
PubMed
Google Scholar
Colagar AH, Firouzjah HM, Halalkhor S. Vitamin D Receptor Poly(A) Microsatellite Polymorphism and 25-Hydroxyvitamin D Serum Levels: association with Susceptibility to Breast Cancer. J Breast Cancer. 2015;18(2):119–25.
Article
PubMed
PubMed Central
Google Scholar
Anderson MG, et al. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol. 2006;57(2):234–40.
Article
CAS
PubMed
Google Scholar
Anderson PH, et al. Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction. J Mol Endocrinol. 2003;31(1):123–32.
Article
CAS
PubMed
Google Scholar
Haussler MR, et al. Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013;92(2):77–98.
Article
CAS
PubMed
Google Scholar
Horvath HC, et al. The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis. J Histochem Cytochem. 2010;58(3):277–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhalehjoo N, Shakiba Y, Panjehpour M. Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissues. Mol Med Rep. 2017;15(1):467–73.
Article
CAS
PubMed
Google Scholar
Shahabi A, et al. Vitamin D receptor gene polymorphism: association with susceptibility to early-onset breast cancer in Iranian, BRCA1/2-mutation carrier and non-carrier patients. Pathol Oncol Res. 2018;24(3):601–7.
Article
CAS
PubMed
Google Scholar
Shahbazi S, et al. BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol. 2013;30(1):393.
Article
PubMed
CAS
Google Scholar
Reid AH, et al. CYP17 inhibition as a hormonal strategy for prostate cancer. Nat Clin Pract Urol. 2008;5(11):610–20.
Article
CAS
PubMed
Google Scholar
Setiawan VW, et al. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2007;16(11):2237–46.
Article
CAS
PubMed
Google Scholar
Ebrahimi E, et al. CYP17 MspA1 gene polymorphism and breast cancer patients according to age of onset in cancer institute of Iran. Iran J Public Health. 2017;46(4):537–44.
PubMed
PubMed Central
Google Scholar
Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 2004;4:1.
PubMed
Google Scholar
Salmaninejad A, et al. Cancer/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Invest. 2016;45(7):619–40.
Article
CAS
PubMed
Google Scholar
Esmaeili R, et al. AKAP3 correlates with triple negative status and disease free survival in breast cancer. BMC Cancer. 2015;15:681.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lim SK, et al. Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor alpha function in breast cancer via the Wnt pathway. FASEB J. 2011;25(9):3004–18.
Article
CAS
PubMed
Google Scholar
Nourashrafeddin S, et al. Expression analysis of PAWP during mouse embryonic stem cell-based spermatogenesis in vitro. Vitro Cell Dev Biol Anim. 2014;50(5):475–81.
Article
CAS
Google Scholar
Nourashrafeddin S, et al. Elevated expression of the testis-specific gene WBP2NL in breast cancer. Biomark Cancer. 2015;7:19–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rastgoosalami M, et al. Evaluation of MAGE-1 cancer-testis antigen expression in invasive breast cancer and its correlation with prognostic factors. Iran J Cancer Prev. 2016;9(4):e4404.
Article
PubMed
PubMed Central
Google Scholar
Dianatpour M, et al. Expression of testis specific genes TSGA10, TEX101 and ODF3 in breast cancer. Iran Red Crescent Med J. 2012;14(11):722–6.
Article
PubMed
PubMed Central
Google Scholar
Nakagawa Y, et al. Outer dense fiber 2 is a widespread centrosome scaffold component preferentially associated with mother centrioles: its identification from isolated centrosomes. Mol Biol Cell. 2001;12(6):1687–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shibata-Minoshima F, et al. Identification of RHOXF2 (PEPP2) as a cancer-promoting gene by expression cloning. Int J Oncol. 2012;40(1):93–8.
CAS
PubMed
Google Scholar
Zou Y, Zhong W. A likely role for a novel PH-domain containing protein, PEPP2, in connecting membrane and cytoskeleton. Biocell. 2012;36(3):127–32.
CAS
PubMed
Google Scholar
Kazemi-Oula G, et al. Upregulation of RHOXF2 and ODF4 expression in breast cancer tissues. Cell J. 2015;17(3):471–7.
PubMed
PubMed Central
Google Scholar
Hsu CC, Tseng LM, Lee HC. Role of mitochondrial dysfunction in cancer progression. Exp Biol Med (Maywood). 2016;241(12):1281–95.
Article
CAS
Google Scholar
Zong WX, Rabinowitz JD, White E. Mitochondria and Cancer. Mol Cell. 2016;61(5):667–76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yadav N, Chandra D. Mitochondrial DNA mutations and breast tumorigenesis. Biochim Biophys Acta. 2013;1836(2):336–44.
CAS
PubMed
PubMed Central
Google Scholar
Damm F, et al. Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia. Leukemia. 2012;26(2):289–95.
Article
CAS
PubMed
Google Scholar
Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 2008;18(4):165–73.
Article
CAS
PubMed
Google Scholar
Arezi P, Rezvani Z. The variation of mitochondrial NADH dehydrogenase subunit 4 (mtND4) and molecular dynamics simulation of SNPs among Iranian women with breast cancer. J Mol Graph Model. 2018;85:242–9.
Article
CAS
PubMed
Google Scholar
Czarnecka AM, et al. Mitochondrial DNA mutations in cancer–from bench to bedside. Front Biosci (Landmark Ed). 2010;15:437–60.
Article
CAS
Google Scholar
Park JS, et al. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet. 2009;18(9):1578–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jonckheere AI, Smeitink JA, Rodenburg RJ. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis. 2012;35(2):211–25.
Article
CAS
PubMed
Google Scholar
Ghaffarpour M, et al. The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients. Cancer Cell Int. 2014;14(1):21.
Article
PubMed
PubMed Central
CAS
Google Scholar